14,800 Hits in 2.0 sec

Interstitial Pneumonias [chapter]

Andrew G. Nicholson
2008 Dail and Hammar's Pulmonary Pathology  
Interstitial Pneumonias Andrew G.  ...  Nicholson of NSIP.  ... 
doi:10.1007/978-0-387-68792-6_19 fatcat:7jvntislcnfu7ostk2vmnbvpou

Exercise-induced haemoptysis: a thoroughbred cause?

James H Hull, Andrew Menzies-Gow, Andrew G Nicholson, Raad H Mohiaddin, Toby M Maher
2013 Thorax  
Professor A G Nicholson (AGN): This demonstrated focally fibrinous organising pneumonia (OP) and moderate haemosiderosis (figure 2 ).  ... 
doi:10.1136/thoraxjnl-2012-202209 pmid:23404840 fatcat:6arz2bauivg4jnifqkje3v4m7i

Endobronchial fibrosarcoma presenting as recurrent left-sided pneumonia

Atul Gupta, Rosemary Marsh, Simon Jordan, Simon Padley, Kareem Aboualfa, Ola Smith, Cyril Fisher, Andrew G. Nicholson, Andrew Bush
2010 Pediatric Pulmonology  
doi:10.1002/ppul.21407 pmid:21560264 fatcat:4446zfuadrheva6cjlsp62sobi

JPWL: JPEG 2000 for wireless applications

Frederic Dufaux, Didier Nicholson, Andrew G. Tescher
2004 Applications of Digital Image Processing XXVII  
2 4 @ E 8 F G I H C 6 P 2 # A 5 % ' 3 5 2 1 ( 4 & E 8 F G I H C 6 P 2 # A 5 % ' 3 5 2 1 ( 4 & 9 % D " ¢ 6 ¢ A B A 8 Q R @ ' 2 S 2 4 3 5 3 5 6 3 8 A E 8 F T U I V W W # W Q R ( 1 A 8 2 1 @ ' !  ...  2 4 @ E 8 F G I H C 6 P 2 # A 5 % ' 3 5 2 1 ( 4 & E 8 F G I H C 6 P 2 # A 5 % ' 3 5 2 1 ( 4 & 9 % D " ¢ 6 ¢ A B A 8 Q R @ ' 2 S 2 4 3 5 3 5 6 3 8 A 2 4 3 5 3 5 6 3 " ¢ 3 5 6 # % ' 2 C % X 6 !  ... 
doi:10.1117/12.564836 fatcat:aroe4obzwfgcnfnqhebq3izyxi

Successful treatment of progressive diffuse PEComatosis

Kay Lawson, Toby M. Maher, David M. Hansell, Andrew G. Nicholson
2012 European Respiratory Journal  
Hansell ",+ and Andrew G.  ...  Nicholson* ," *Dept of Histopathology, Imperial College, # Interstitial Lung Disease Unit, Imperial College, " Royal Brompton and Harefield Hospitals NHS Foundation Trust, and National Heart and Lung Institute  ...  mL -1 ; subcutaneous octreotide (100 mg three times daily); and a medium-chain triglyceride (MCT) diet (aiming for a dietary fat content of ,14 g?day -1 ).  ... 
doi:10.1183/09031936.00076411 pmid:23204027 fatcat:qecujrfhpveaxeyiweeclruxju

Pulmonary manifestation of systemic karyomegaly

Levent M. Akyürek, Aziz Hussein, Andrew G. Nicholson, Nils-Johan Mauritz, Johan Mölne
2020 Respiratory Medicine Case Reports  
Over 40 years ago, abnormal enlargement of the nucleus of tubular epithelial cells was reported in a rare distinct hereditary chronic interstitial nephritis, karyomegalic interstitial nephritis (KIN). Here, we report the second case of systemic karyomegaly with pulmonary manifestations and present a detailed characterization of the karyomegalic cells in lung parenchyma. A 59-year-old woman who was diagnosed with KIN developed renal failure and eventually received a renal transplant later
more » ... ed for chronic and progressive restrictive lung disease. The KIN diagnosis prompted us to carefully examine her lung parenchyma. Karyomegalic cells were identified in the alveolar epithelium, interstitium, as well as, in the vascular wall. Viral serological and biochemical blood analyses were negative. We consider that the pulmonary manifestations of karyomegaly expands the differential diagnosis of interstitial lung disease in patients with KIN.
doi:10.1016/j.rmcr.2020.101032 pmid:32154101 pmcid:PMC7058920 fatcat:a6xlwhxgtbc7blzrlsk7zqje4m

E12-03: Intra-operative pathology consultation - novel approaches to frozen section

Andrew G. Nicholson
2007 Journal of Thoracic Oncology  
E12-03 Recent Adv and Future Prospective in LC Pathology, Tue, Sept 4, 16:00 -17:30 Intra-operative pathology consultation -novel approaches to frozen section Nicholson, Andrew G.  ... 
doi:10.1097/01.jto.0000283032.58799.1f fatcat:mvqil5pjzbhapnny5mlmk4fase

Inhalational anthrax in a vaccinated soldier

Annemarie Sykes, Tim Brooks, Michael Dusmet, Andrew G. Nicholson, David M. Hansell, Robert Wilson
2013 European Respiratory Journal  
doi:10.1183/09031936.00201112 pmid:23813313 fatcat:v3wng4afyzc4rchfisovunl3ry

COVID‐19 related lung pathology: old patterns in new clothing?

Andrew G Nicholson, Michael Osborn, Anand Devaraj, Athol U Wells
2020 Histopathology  
doi:10.1111/his.14162 pmid:32881045 fatcat:zf4hlemorrfdxeewqbzcxlakj4

Research in progress: put the orphanage out of business: Table 1

Andrew Bush, Gisela Anthony, Angelo Barbato, Steve Cunningham, Annick Clement, R Epaud, Carlee Gilbert, Lutz Goldbeck, Kai Kronfeld, Andrew G Nicholson, Nicolaus Schwerk, Matthias Griese
2013 Thorax  
doi:10.1136/thoraxjnl-2012-203201 pmid:23429832 fatcat:nuftdzpnibflbfr4xvhoomzyaq

Diffuse granulomatous disease: looking inside and outside the lungs

Alan Williams, W Peter Kelleher, Andrew G Nicholson, Anand Devaraj, Carlos Pavesio, Felix Chua
2020 Thorax  
ProFessor AnDreW niCholson Biopsies from two sites showed architecturally normal lung with numerous ill-defined, often bronchocentric nodules comprising a dense lymphoid infiltrate of small round lymphocytes  ...  whole antibody titre (<3.3 µg/ mL, ref:>20) and tetanus toxoid IgG whole antibody titre (0.1 IU/mL, ref: protective ≥0.15 IU/ mL) were also reduced suggesting impaired T and B cell-dependent antibody responses  ... 
doi:10.1136/thoraxjnl-2019-213797 pmid:31907202 pmcid:PMC7029226 fatcat:5aqqycg4bffdtf43e4basbdz6m

Interstitial pneumonia with autoimmune features: challenges and controversies

John A. Mackintosh, Athol U. Wells, Vincent Cottin, Andrew G. Nicholson, Elisabetta A. Renzoni
2021 European Respiratory Review  
Nicholson reports consulting fees received from Galapagos, Boehringer Ingelheim, Roche and Medical Quantitative Image Analysis in relation to idiopathic pulmonary fibrosis, outside the submitted work;  ... 
doi:10.1183/16000617.0177-2021 pmid:34937706 fatcat:kavkslsw25bwzmccxozjjlbq5i

Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study

Christiane Lex, Angela Zacharasiewicz, Donald NR Payne, Nicola M Wilson, Andrew G Nicholson, Sergei A Kharitonov, Peter J Barnes, Andrew Bush
2006 Respiratory Research  
Moderate to severe persistent asthma was characterised by "daily symptoms despite >400 µg of inhaled budesonide (or equivalent)" [8] . 21/ 29 asthmatic children received additional treatment with systemic  ...  (4-15) Male, n 16 Atopic*, n 21 Duration of symptoms (years) 10.0 (5.0-12.0) FEV 1 (% predicted)# 80 (64-91) Treatment in previous 2 weeks Inhaled steroid dosage (budesonide equivalent) (µg/  ... 
doi:10.1186/1465-9921-7-63 pmid:16603074 pmcid:PMC1456970 fatcat:qj7jk7k64zhznahc5lcrbmbrmu

Endobronchial ultrasound: morphological predictors of benign disease

Pratibha Gogia, Tabassum Z. Insaf, William McNulty, Afroditi Boutou, Andrew G. Nicholson, Zaid Zoumot, Pallav L. Shah
2016 ERJ Open Research  
The objective of this study was to assess the utility of endobronchial ultrasound (EBUS) morphology of lymph nodes in predicting benign cytology of transbronchial needle aspirates in a prospective observational study. Five ultrasonic morphological characteristics of mediastinal and hilar lymph nodes were recorded: size, shape, margins, echogenic appearance and the presence of a central blood vessel. These characteristics were correlated with the final diagnosis. A total of 402 consecutive
more » ... ts (237 males and 165 females) undergoing EBUS were studied. The final diagnosis was malignant disease in 244 (60.6%) and benign disease in 153 (38.05%) subjects. Out of 740 sampled nodes, in 463 (62.6%) malignant cells were identified, whereas in 270 (36.5%) nodes, no malignant cells were identified. On univariate analysis small size, triangular shape and the presence of a central vessel were predictive of a benign aetiology. In the final multivariate model, a predictive probability of 0.811 (95% CI 0.72-0.91) for benign disease was found if lymph node size was <10 mm and a central vessel was present. Sonographic appearances of lymph nodes improve the predictive probability of EBUS for benign aetiologies, and may reduce the number of nodes requiring sampling and the need for further invasive investigations. @ERSpublications Node size <10 mm, central vessels and triangular shape on EBUS increase confidence in cytology of a benign aetiology
doi:10.1183/23120541.00053-2015 pmid:27730169 pmcid:PMC5005152 fatcat:zbkilyc4t5grvbxdcc7pt5cd54

Certified causes of death in patients with mesothelioma in South East England

Catherine Okello, Tom Treasure, Andrew G Nicholson, Julian Peto, Henrik Møller
2009 BMC Cancer  
Mesothelioma is a highly fatal cancer that is caused by exposure to asbestos fibres. In many populations, the occurrence of mesothelioma is monitored with the use of mortality data from death certification. We examine certified causes of death of patients who have been diagnosed with mesothelioma, and assess the validity of death certification data as a proxy for mesothelioma incidence.
doi:10.1186/1471-2407-9-28 pmid:19166594 pmcid:PMC2639607 fatcat:qzxvqsrpsbhg3ipnvp7yjbavee
« Previous Showing results 1 — 15 out of 14,800 results